REQUEST A DEMO
Total
USD $0.00
Search more companies

Jjp Biologics Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Jjp Biologics Sp. z o.o. Profile Updated: May 03, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Jjp Biologics Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The company was established on March 23, 2016. 1 (2016) employees currently work for Jjp Biologics Sp. z o.o.. A growth of 76.21% was recorded in its total assets.

Headquarters
Ul. Bobrowiecka 8
Warsaw; Mazowieckie; Postal Code: 00-728

Contact Details: Purchase the Jjp Biologics Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Jjp Biologics Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Jjp Biologics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Jjp Biologics Sp. z o.o. report to view the information.
Incorporation Date:
March 23, 2016
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Jjp Biologics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
27740163.48%
Operating profit (EBIT)
4.23%
EBITDA
4.36%
Net Profit (Loss) for the Period
-7.07%
Total assets
76.21%
Total equity
-4.44%
Return on Equity (ROE)
-6.19%
Quick Ratio
9.75%
Cash Ratio
7.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?